Patient-Reported Outcome Measures (PROMS) in Lymphoma

Area of Science:

• Oncology
• Clinical Research
• Patient-Centered Outcomes

Background:

• Patient-reported outcome measures (PROMs) are increasingly utilized in lymphoma research to evaluate treatment impact on patient experience.
• Regulatory agencies support PROMs in patient-focused drug development, yet their application, analysis, and reporting remain inconsistent.
• Heterogeneity in PROM utilization poses challenges for standardized interpretation and integration into clinical practice.

Purpose of the Study:

• To systematically review the current application of PROMs in lymphoma patient care.
• To identify the specific domains measured by PROMs in lymphoma and their clinical significance.
• To explore the links between PROMs and clinical outcomes and identify gaps for future research and clinical trial design.

Main Methods:

• Systematic evidence-based review of literature concerning PROMs in lymphoma.
• Analysis of PROM usage patterns, measured domains, and reported clinical significance.
• Evaluation of the association between PROMs and clinical outcomes.

Main Results:

• PROMs are widely used but applied heterogeneously across studies and clinical settings for lymphoma patients.
• Key domains measured include symptom burden, quality of life, and functional status.
• Evidence linking PROMs to objective clinical outcomes is developing but requires further robust investigation.

Conclusions:

• Standardizing the use, analysis, and reporting of PROMs is crucial for lymphoma research and clinical decision-making.
• Further research is needed to strengthen the evidence base for PROMs as reliable endpoints in clinical trials.
• Addressing identified gaps will enhance the integration of patient perspectives into lymphoma treatment evaluation and drug development.